PDF) The CRISPR tool kit for genome editing and beyond
CRISPR-Cas9 babies likely to die earlier, Berkeley study says | Science| In-depth reporting on science and technology | DW | 03.06.2019
CRISPR/Cas9 – An evolving biological tool kit for cancer biology and oncology | npj Precision Oncology
Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research: Molecular Therapy - Methods & Clinical Development
The next generation of CRISPR–Cas technologies and applications | Nature Reviews Molecular Cell Biology
Developing CRISPR/CAS9 technologies for research and medicine - MedCrave online
A CRISPR Approach to Treating Sickle Cell – NIH Director's Blog
CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response | Nature Medicine
CRISPR-engineered T cells in patients with refractory cancer | Science
Untangling the CRISPR cancer scare
CRISPR, the disruptor : Nature News & Comment
Development of a CRISPR/Cas9-based therapy for Hutchinson–Gilford progeria syndrome | Request PDF
Is Crispr the Next Antibiotic? - The New York Times
CRISPR algorithm predicts how well gene editing will work - Scope
Super-precise new CRISPR tool could tackle a plethora of genetic diseases
p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells | Nature Medicine
A new research revealed that the CRISPR–Cas9 genome editing technique may increase cancer risk - Biotech Advisers
CRISPR-Edited Cells Linked to Cancer Risk in 2 Studies - Scientific American
Nature Medicine》基因编辑工具增加致癌隐患- 生物通
Precision CRISPR system averts hearing loss in mice - Boston Children's Discoveries
Nature Medicine - About the cover: Using CRISPR-Cas9–based genome editing technology, Sato and colleagues (featured on p 256 of this month's issue) introduce various combinations of mutations associated with human intestinal tumors
Single-dose CRISPR-Cas9 therapy extends lifespan of mice with Hutchinson-Gilford progeria syndrome. - Nat. Med. - X-MOL
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects | Signal Transduction and Targeted Therapy
CRISPR, the disruptor : Nature News & Comment
